Neogen Corp
(NASDAQ: NEOG)
+0.29
+0.53%
| Exchange: | NASDAQ |
| Stock: | Neogen Corporation |
| Industry: | Diagnostic Substances |
| Employees: | 746 |
| Neogen Corporation (Neogen), together with its subsidiaries, develops, manufactures, and markets a diverse line of products dedicated to food and animal safety. It is engaged in developing and marketing test kits that provide food safety solutions. The Company’s food safety segment consists primarily of diagnostic test kits and complementary products (dehydrated culture media) sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, drug residues, pesticide residues and general sanitation concerns. These products are marketed in North America, the United Kingdom and other parts of Europe, Mexico and Brazil and by distributors through the rest of the world. In October 2012, it acquired the stock of Macleod Pharmaceuticals. In January 2013, the Company acquired the assets of Scidera Genomics, LLC. |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
